194 related articles for article (PubMed ID: 30655335)
1. Public Health Surveillance of Prenatal Opioid Exposure in Mothers and Infants.
Honein MA; Boyle C; Redfield RR
Pediatrics; 2019 Mar; 143(3):. PubMed ID: 30655335
[TBL] [Abstract][Full Text] [Related]
2. Identifying Co-Exposure to Opiates and Gabapentin During Pregnancy.
Loudin S; Haas J; Payne M; Linz MF; Meaney-Delman D; Honein MA; Saunders A
J Pediatr; 2020 Feb; 217():196-198. PubMed ID: 31668481
[TBL] [Abstract][Full Text] [Related]
3. Women, Infants, and Opioids.
Lowe NK
J Obstet Gynecol Neonatal Nurs; 2017; 46(5):657-659. PubMed ID: 28802558
[No Abstract] [Full Text] [Related]
4. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
[TBL] [Abstract][Full Text] [Related]
5. Statewide Task Force on Prescription Drug Abuse and Newborns Update: Neonatal Abstinence Syndrome Data Summary.
Fla Nurse; 2015 Jun; 63(2):14. PubMed ID: 26259378
[No Abstract] [Full Text] [Related]
6. Accuracy of diagnostic codes for prenatal opioid exposure and neonatal opioid withdrawal syndrome.
Kuzniewicz MW; Campbell CI; Li S; Walsh EM; Croen LA; Comer SD; Pimentel SD; Hedderson M; Sun LS
J Perinatol; 2023 Mar; 43(3):293-299. PubMed ID: 36131095
[TBL] [Abstract][Full Text] [Related]
7. Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure.
Faherty LJ; Matone M; Passarella M; Lorch S
Matern Child Health J; 2018 Jun; 22(6):841-848. PubMed ID: 29417369
[TBL] [Abstract][Full Text] [Related]
8. Time for the Finnegan Neonatal Abstinence Syndrome Scoring Tool to Be Retired?
Verklan MT
J Perinat Neonatal Nurs; 2019; 33(3):276-277. PubMed ID: 31335858
[No Abstract] [Full Text] [Related]
9. Newborns exposed to opioids need mothers more than NICU, say pediatricians.
Vogel L
CMAJ; 2018 Jan; 190(4):E123-E124. PubMed ID: 29378878
[No Abstract] [Full Text] [Related]
10. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
[TBL] [Abstract][Full Text] [Related]
11. Infants of opioid-dependent mothers: neurodevelopment at six months.
McGlone L; Mactier H
Early Hum Dev; 2015 Jan; 91(1):19-21. PubMed ID: 25460252
[TBL] [Abstract][Full Text] [Related]
12. Neonatal Abstinence Syndrome.
Jansson LM; Patrick SW
Pediatr Clin North Am; 2019 Apr; 66(2):353-367. PubMed ID: 30819342
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of Intrauterine Opioid Exposures Using Electronic Health Records.
Hall ES; Wexelblatt SL; Greenberg JM
Popul Health Manag; 2018 Dec; 21(6):486-492. PubMed ID: 29485940
[TBL] [Abstract][Full Text] [Related]
14. Implications of Tennessee's Opioid Legislation for Neonatal Abstinence Syndrome.
Shearer JN; Erwin PC; Davis SK; Anderson JG; Lindley LC
Policy Polit Nurs Pract; 2019 Aug; 20(3):153-162. PubMed ID: 31390304
[TBL] [Abstract][Full Text] [Related]
15. Opioids in pregnancy and neonatal abstinence syndrome.
Stover MW; Davis JM
Semin Perinatol; 2015 Nov; 39(7):561-5. PubMed ID: 26452318
[TBL] [Abstract][Full Text] [Related]
16. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
[TBL] [Abstract][Full Text] [Related]
17. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
McQueen KA; Murphy-Oikonen J; Desaulniers L
Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
[TBL] [Abstract][Full Text] [Related]
18. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.
Huybrechts KF; Bateman BT; Desai RJ; Hernandez-Diaz S; Rough K; Mogun H; Kerzner LS; Davis JM; Stover M; Bartels D; Cottral J; Patorno E
BMJ; 2017 Aug; 358():j3326. PubMed ID: 28768628
[No Abstract] [Full Text] [Related]
19. Identification of early developmental deficits in infants with prenatal heroin, methadone, and other opioid exposure.
Beckwith AM; Burke SA
Clin Pediatr (Phila); 2015 Apr; 54(4):328-35. PubMed ID: 25189695
[TBL] [Abstract][Full Text] [Related]
20. Identification of Substance-Exposed Newborns and Neonatal Abstinence Syndrome Using ICD-10-CM - 15 Hospitals, Massachusetts, 2017.
Goyal S; Saunders KC; Moore CS; Fillo KT; Ko JY; Manning SE; Shapiro-Mendoza C; Gupta M; Romero L; Coy KC; McDow KB; Keaton AA; Sinatra J; Jones K; Alpren C; Barfield WD; Diop H
MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):951-955. PubMed ID: 32701936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
